$OSCR
$UNH (-1,98%)
$CNC (+0,88%)
$CVS (+0,27%)

A federal judge paused parts of the U.S. planned regulatory changes by the Department of Health and Human Services on Friday to the Affordable Care Act's health insurance marketplace, just days before they were set to take effect.

https://www.reuters.com/legal/litigation/us-judge-pauses-changes-federal-health-insurance-marketplace-2025-08-22/

$UNH (-1,98%)
$BRK.B (+0,02%)
$BRK.A (-0,12%)

Buffett has probably bought far more than the stated 5 million shares of $UNH (-1,98%) probably much more.

This can be concluded from the fact that Berkshire Hathaway no longer requires a confidentiality note for the current quarter.

Today's 13F only covers transactions through June 30, we don't know how much he bought after that.

The closing price on this day for $UNH (-1,98%) was $311.97.

In between there are another 45 days where the price has mostly fallen further.

Therefore, confidential treatment of $BRK.B (+0,02%) is no longer necessary.

We will find out exactly how much he has collected in 3 months, but I believe that he was not satisfied with the initial purchase with the share price continuing to fall and so much cash on hand 💪

Other buyers:

• Tepper
• Burry
• Simons - Renaissance

$CNC (+0,88%)
$OSCR
$CVS (+0,27%)
$CI (-0,97%)
$ELV (+2,7%)

$UNH (-1,98%)
$CNC (+0,88%)
$US60855R1005 (+2,12%)
$ELV (+2,7%)
$CVS (+0,27%)

How the loss of $CNC (+0,88%) and $US60855R1005 (+2,12%) shows, Medicaid is charity care because you lose money when you care for the sickest and poorest population. To make a profit, you want as few Medicaid patients as possible.

$UNH (-1,98%) is in a better position ✌️

$CNC (+0,88%)

Next sale in the health insurance sector ?

🔹 Revenue: USD 48.74 billion (estimated USD 44.24 billion) ✅

🔹 Adjusted earnings per share: ( USD 0.16) (estimated USD 0.23) ❌

🔹 Health insurance ratio: 93.0% (estimated 91.6%) ❌ ; increase of +5.4 percentage points compared to the previous year

🔹 Total income from premiums and services: USD 42.47 billion; increase of 18% compared to the previous year

🔹 Selling and administrative expenses ratio: 7.1 %

Segment revenue:

🔹 Medicaid: USD 21.72 billion; increase of 7% compared to the previous year

Commercial: USD 10.07 billion; increase of 18% compared to the previous year

🔹 Medicare: USD 9.45 billion; increase of 58% compared to the previous year

🔹 Other: USD 1.22 billion; increase of 1% compared to the previous year

Other metrics

🔹 Cash flow from operating activities: USD 1.79 billion

🔹 Payability days for claims: 47 days

CEO comment:

➡️ "We are disappointed with our second quarter results, but have a clear understanding of the trends that impacted our performance and are working diligently and with focus to restore our earnings performance." - Sarah M. London

➡️ "Despite the changing landscape, we believe the staying power of Medicaid, Medicare and the Individual Marketplace is stronger than ever." - Sarah M. London

$UNH (-1,98%)
$US60855R1005 (+2,12%)
$CVS (+0,27%)
$CI (-0,97%)
$XDWH (+0,56%)

$XDWH (+0,56%)
$XLV (+0,59%)
$CSPX (+0,86%)
$VUSA (+0,7%)
$UNH (-1,98%)
$OSCR

According to Goldman Sachs, healthcare is the only sector in the S& P 500 that is cheaper than the 10- and 30-year averages.

This is an extremely attractive risk/reward ratio and the coming months will be exciting.

$ELV (+2,7%)
$CNC (+0,88%)
$DHR (+0,68%)
$SRT (+3,48%)
$LLY (+0,36%)
$NOVO B (+6,8%)
$NVO (+6,86%)
$ISRG (+0,39%)
$JNJ (-1,15%)
$ABBV (+0,75%)
$PFE (+0,59%)
$SAN (+1,33%)
$MRK (+0,73%)
$BMY (-1,22%)
$TMO (+3,56%)

$ELV (+2,7%)

• EPS: $8.84 vs $9.07 expected ❌
• Revenue: $49.4 billion vs $48.14 billion expected ✅
• FY25 EPS guidance: $30.00 vs $34.48 consensus ❌

• Benefit cost ratio: 88.9%; increase of +260 basis points compared to the previous year
• Operating expense ratio: 10.1 %; decrease of -160 basis points compared to the previous year

The second-largest health insurer reported its profits. Although these were below consensus, they were not too bad given the panic in the industry.

The benefit cost ratio was 88.9%, an increase of 260 basis points from the previous year, reflecting the trend toward higher medical costs, particularly in the Medicaid business and ACA health plans.

CEO Comment:

• "In the second quarter, Elevance Health made significant progress in delivering a simple and personalized experience for our customers while advancing our efforts to improve efficiencies across the health system ... With the embedded earnings power of our diversified Health Benefits and Carelon businesses, we remain confident in our ability to deliver at least 12% compound annual growth in adjusted diluted earnings per share over time." - Gail K. Boudreaux

$UNH (-1,98%)
$CNC (+0,88%)
$US60855R1005 (+2,12%)
$CVS (+0,27%)
$OSCR

$UNH (-1,98%)

$UNH (-1,98%) has not experienced two consecutive years of negative returns since 1987.

Who is still invested here, who is buying, what are your assessments? 🤔

In my opinion, a lot of negative things are already priced in here.

• There is no evidence for the accusations
• Every accusation is contradicted and more openness is also suggested
• They are regularly reviewed and nothing negative has been found
• Bad "old" news is constantly being rehashed which has already been dismissed as unfounded and unproven
• CEO and other insiders have set an example by buying it
• $UNH (-1,98%) is one of the largest employers in the US and also system relevant
• Medicare/Medicaid accounts for only 15% of revenue
• Outlook/expectations have already been reduced
• Historically high dividend yield of just under 3%
• Possible penalties already priced in in my opinion

yes, of course there is still downside potential, but the risk/reward ratio is already very attractive

The entire sector has similar ways of working and a decline/reduction in Medicare could $UNH (-1,98%) as the top dog in the private sector could even play into its hands.

UnitedHealth Group $UNH (-1,98%) has traded at the largest deviation from the S&P 500 price-to-earnings ratio since its IPO ...

This stock has literally NEVER been this cheap relative to the S&P 500.

Incredibly exciting to follow the story.

$CNC (+0,88%)
$CVS (+0,27%)
$OSCR
$HUM (+0,61%)
$CI (-0,97%)
$ELV (+2,7%)
$XDWH (+0,56%)

$CNC (+0,88%)
$CI (-0,97%)
$OSCR
$UNH (-1,98%)
$HUM (+0,61%)
$CVS (+0,27%)

$CNC (+0,88%) Centene has withdrawn its earnings guidance for 2025 after new data showed significantly higher morbidity and lower than expected growth in the Marketplace business. This resulted in a decline in net revenue from risk adjustment of approximately $1.8 billion and a decline in earnings of approximately $2.75 per share. Medicaid costs are also rising, particularly in the areas of mental health, home care and expensive drugs in states such as New York and Florida. $CNC (+0,88%) plans a price correction for 2026 and will provide more information in its Q2 results on July 25.

Oscar Health $OSCR is also down due to its high presence in this area, as are other insurance stocks such as $HUM (+0,61%) , $CI (-0,97%) and $UNH (-1,98%) . $CNC (+0,88%) will announce further details on its Q2 results on July 25.

Centene $CNC (+0,88%) has withdrawn its forecast for 2025 due to rising ACA/Medicaid costs. (The Affordable Care Act (ACA), also known as ObamacareACA) accounts for 72% of the business of $CNC (+0,88%) business.

$UNH (-1,98%) has withdrawn from many ACA markets and it now accounts for only a small part of their business.

$CNC (+0,88%) also reported that Medicare Advantage plans are doing better than expected, could be a positive for $UNH (-1,98%) positive as many people now have to self-insure.